The understanding on how the immune response could be modulated in order to prevent the differentiation of CD8+T cells into malaria-specific effector cells, and/or to prevent their migration into the lungs, strongly supports the development of approaches that can target this pathogenic pathway to treat malaria-associated ARDS. Here, CD8A is linked to acute respiratory distress syndrome.